Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Posts tagged Ian Cassel

Intelligent Fanatic Ka Stock Nahin Dubega: Investors Stay In Denial Despite Colossal Losses



Kitex Garments Sabu Jacob

A stock which is headed by a so-called “intelligent fanatic” attracted the crème-de-la-crème of investors. They ignored the warnings that were writ large and are now wailing inconsolably at the colossal losses

Jatin Khemani Of Stalwart Advisors Stuns With 725% Multibagger Gain From Micro-Cap Stock



An unknown micro-cap stock recommended by Jatin Khemani of Stalwart Advisors has given a mind-boggling gain of 725% in just 22 months. We need to immediately probe into his other stock recommendations and check whether there are any other potential mega-bagger stocks ripe for the picking

Guide To Finding Potential Multi-Bagger Stocks From Unknown Micro-Cap Stocks



Ian Cassel, the founder of Micro Cap Club, has offered valuable guidance on how we can find unknown micro-cap stocks that have the potential to become huge multi-baggers and generate enormous wealth. He has explained the theory with reference to real-life case studies of micro-cap stocks that have in fact become mega-baggers

Prof. Sanjay Bakshi’s Stock Picking Wizardry Results In Mega Gains For ValueQuest India Moat Fund



Prof. Sanjay Bakshi has revealed hitherto unknown facts about his ValueQuest India Moat Fund. The Fund has an AUM of Rs. 4000 crore and has clocked in impressive gains of 105% in FY 2014-15

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 494 other subscribers

RSS Stocks Talk Forum

  • Shalby is a multi-specialty hospital chain with expertise in joint replacement
    Shalby is a multi-specialty hospital chain with expertise in joint replacement. It is making right strides with calibrated growth based on big ticket expansion in metros & tier I cities & asset-light franchisee expansion in tier II-VI towns. TP ₹310 (35%) Download... Shalby is a multi-specialty hospital chain with expertise in joint replacement
  • DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
    DLF has strong growth prospects due to strong sectoral tailwinds, record low inventory, greater preference for branded luxury, extensive launch pipeline & expansion in its annuity portfolio. Strong Balance Sheet with consistent cash flow. TP ₹1081 (+30%) Research Report... DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
  • Aditya Birla Capital has demonstrated solid performance. Buy for target price of ₹280 (37% upside)
    Aditya Birla Capital has demonstrated solid performance, achieving strong growth in the loan book while maintaining asset quality. Management has reiterated guidance on both growth & credit cost fronts. Lending business expected to grow at 30%. TP (+37%)... Aditya Birla Capital has demonstrated solid performance. Buy for target price of ₹280 (37% upside)
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!